Noumed Period Pain Relief (Naproxen)

Naproxen, the active ingredient in Noumed Period Pain Relief, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats menstrual pain and dysmenorrhea in women of reproductive age.

GNH USA supplies Noumed Period Pain Relief as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen is an NSAID that alleviates pain and inflammation associated with menstrual disorders.

Menstrual pain: provides analgesic relief of cramping during menstruation. Primary dysmenorrhea: reduces uterine prostaglandin‑mediated pain. Secondary dysmenorrhea: alleviates pain linked to underlying pelvic pathology.

Naproxen may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dyspepsia or stomach upset - Heartburn or acid reflux - Nausea or vomiting - Dizziness or light‑headedness - Headache - Mild skin rash

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration - Severe allergic reactions such as Stevens‑Johnson syndrome - Cardiovascular events including myocardial infarction - Elevated liver enzymes indicating hepatic injury - Acute kidney injury or reduced renal function - Thrombotic thrombocytopenic purpura (very rare)

Before using Naproxen, consider the following safety measures.

Assess gastrointestinal risk: avoid in patients with active ulcers or history of GI bleeding. Evaluate cardiovascular history: use cautiously in those with heart disease or stroke risk. Monitor renal function: adjust or discontinue if kidney impairment develops. Avoid in known hypersensitivity: discontinue if allergic reactions occur. Use the lowest effective dose for the shortest duration needed. Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Naproxen can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - SSRIs or SNRIs: amplified risk of GI bleeding. - Lithium: elevated lithium serum levels. - Corticosteroids: additive ulcerogenic effect.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in renal clearance. - Antihypertensives (ACE inhibitors, ARBs): may diminish blood pressure control. - Methotrexate: decreased clearance leading to toxicity. - Digoxin: potential increase in serum concentration.